Development of mobile compatible software for cognitive-communication disorder in individuals with Alzheimer's disease.

Only 32 people took part, all from one clinic in Turkey. With six mild, six moderate and four severe patients in each group, the stage-by-stage findings rest on very small numbers. Nobody recorded how much the app was actually used. The app did not track time, so how often and how long people practised at home is only what families reported, and the authors list this as a limitation. The study ran for seven weeks with no follow-up, so there is no evidence that any gain lasted. The app bundles several approaches together (reality orientation, cognitive stimulation, reminiscence, language exercises and a communication board). Nothing here shows which of them, if any, produced the changes. Participants and families knew which group the patient was in, and the ratings and the reported changes at home come from those families, so expectations may have coloured them. Naming did not improve as much as the authors hoped, and they say this is because the pictures were ready-made rather than the patient's own. The families of people with dementia were not consulted when the app's content was chosen. Caregiver quality of life and care burden were not measured, and no information about caregivers was collected. Participants had on average about three years of schooling, and all had already been on acetylcholinesterase inhibitors for at least three months, so this group may not reflect other patients. The results text says attention and calculation declined in the study group, which contradicts the study's own table showing that decline in the control group, so individual p-values should be read with care.

The authors declare no conflicts of interest. The text provided contains no funding statement. The app was designed and written by the speech and language therapists who then ran the trial, so the people who built the tool also tested it.

Do not take this as proof that the app holds back Alzheimer's decline. Thirty-two people at one clinic used it on top of their usual medication, nobody recorded how much anyone actually used it at home, and the study lasted only seven weeks with no follow-up. The two groups did not differ on the language test total (p = 0.485), and families knew which group the patient was in, so their reports of improvement may reflect expectation.